CoreWeave (CRWV) Chief Development Officer McBee Brannin sold Class A common stock on June 29 and 30, totaling approximately $5.47 million, with share sale prices ranging from $90.227 to $98.31 per share; following the transactions, CRWV stock dropped to $85.69, below the overall sale price range.
June 29 Sale of 500 Shares: Executed Under 10b5-1 Plan
According to SEC filings, on June 29, 2026, Brannin sold 500 shares of CRWV Class A common stock, executed under a 10b5-1 trading plan adopted on March 5, 2026. The shares were indirectly held through the Canis Major SM Trust, an irrevocable trust with Brannin's minor children as beneficiaries, and Brannin retains the right to replace the trustee.
June 30 Sale of 56,707 Shares: Used to Pay RSU Withholding Taxes
According to SEC filings, on June 30, Brannin sold 56,707 shares of Class A common stock to satisfy withholding tax obligations arising from the vesting and settlement of RSUs. On the same day, Brannin acquired 121,118 shares of Class A common stock through RSU vesting; each RSU represents a contingent right to receive one share of CoreWeave Class A common stock upon settlement, with awards generally vesting quarterly subject to Brannin's continued service.
Post-Transaction Holdings: 323,263 Shares of Class A Directly Held
According to SEC filings, after all transactions, Brannin's holdings are as follows:
Class A Common Stock (directly held): 323,263 shares
Class A Common Stock (indirectly held via Canis Major SM Trust): 52,000 shares
Class A Common Stock (held by children): 1,800 shares
Class B Common Stock (Canis Major 2025 Family Trust LLC, Brannin as manager): 108,600 shares, convertible 1:1 to Class A
Class B Common Stock (Canis Major 2026 GRAT, Brannin as sole trustee and beneficiary): 1,582,773 shares, convertible 1:1 to Class A
Class B Common Stock (GRAT, spouse as sole beneficiary and trustee): 263,795 shares, convertible 1:1 to Class A
Unvested RSUs: 1,222,887 units (Canis Minor related trust holdings are not cited due to incomplete original filing data)
Evercore ISI Maintains Target Price of $150
According to reports, Evercore ISI reaffirmed its "Outperform" rating on CoreWeave with a $150 target price; previously, Evercore ISI updated its 2026 and 2027 fiscal year earnings per share estimates due to adjustments in tax accounting and interest expense timing, resulting in widened loss expectations.
Rosenblatt initiated coverage on CoreWeave with a "Buy" rating and a $250 target price, highlighting CoreWeave as a key AI infrastructure provider.
ARIA Preview Released, W&B Weave Platform Launched
According to an official CoreWeave announcement, CoreWeave launched the ARIA preview, an AI research agent designed to analyze experimental data in Weights & Biases to enhance model and agent development efficiency; ARIA is built on CoreWeave's W&B Weave platform, which is now generally available.
Additionally, a Bloomberg report on Meta Platforms developing a cloud infrastructure business impacted CRWV stock movement, as Meta Platforms plans to offer AI computing power and model capabilities similar to CoreWeave; CoreWeave's Q1 2026 order backlog is reported to be $100 billion.
Frequently Asked Questions
What was the purpose of McBee Brannin's sale of CoreWeave stock?
According to SEC filings, the sale of 500 shares on June 29 was executed under a 10b5-1 plan adopted on March 5, 2026; the sale of 56,707 shares on June 30 was to satisfy withholding tax obligations from the vesting and settlement of restricted stock units (RSUs).
How does the average sale price of CoreWeave stock compare to the current market price?
According to filings, Brannin's stock sale prices ranged from $90.227 to $98.31 per share; following the transactions, CRWV stock fell to $85.69, below the overall sale price range.
What are the ratings and target prices for CoreWeave from Rosenblatt and Evercore ISI?
According to reports, Evercore ISI maintains an "Outperform" rating and a $150 target price; Rosenblatt initiated coverage with a "Buy" rating and a $250 target price.
